Target- |
MechanismImmunostimulants |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. |
First Approval Date30 Dec 1997 |
/ Not yet recruitingPhase 2 Iron deficinency and heart failure
100 Clinical Results associated with Mimer Medical AB
0 Patents (Medical) associated with Mimer Medical AB
100 Deals associated with Mimer Medical AB
100 Translational Medicine associated with Mimer Medical AB